Oct 13 (Reuters) - The U.S. government has awarded diagnostic testing company Cue Health Inc $481 million to scale up the production of rapid COVID-19 molecular test, the Department of Health and ...
The FDA granted emergency use authorization June 12 to healthcare tech company Cue Heath’s rapid COVID-19 test. The single-use molecular test identifies the RNA of the virus that causes COVID-19 from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback